nsclc: immunotherapy beyond progression
Published 6 years ago • 560 plays • Length 7:13Download video MP4
Download video MP3
Similar videos
-
4:09
using immunotherapy beyond progression in nsclc
-
7:13
continuing immunotherapy beyond progression
-
6:04
isolated progression of nsclc on immunotherapy
-
1:15
dr. brahmer on immunotherapy beyond pd-1/l1 in nsclc
-
5:22
treatment for nsclc after progression on immunotherapy
-
3:34
clinical outcomes of immunotherapy after radiographic progression in advanced nsclc
-
5:47
defining progression of nsclc on immunotherapy
-
5:58
continuing/re-challenging with i-o therapy in nsclc
-
8:22
what to do after progression on immunotherapy and for non-driver nsclc
-
1:00:44
practical application of recent clinical data for immunotherapy in nsclc
-
2:38
progression on immunotherapy: treatment approach
-
5:49
various forms of disease progression in advanced nsclc
-
6:15
treatment beyond progression for metastatic rcc
-
48:15
immunotherapy for lung cancer: pd-1 and beyond, with naiyer rizvi
-
1:47
dr. clarke on combination approaches beyond progression on osimertinib in lung cancer
-
1:03
dr. costa on biomarkers beyond pd-l1 for immunotherapy in nsclc
-
5:02
going beyond pd-l1 testing for lung cancer immunotherapy
-
3:28
treating beyond progression in egfr-mutant lung cancer
-
1:02:36
practice changes for use of immunotherapy in nsclc